(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are Gevo, ICU Medical, and Methes Energies International Ltd.

Rank Financial Asset Price Change Updated (EST)
1 Gevo (GEVO) 7.94 37.13% 2021-09-09 15:08:44
2 ICU Medical (ICUI) 260.00 26.23% 2021-09-09 05:07:14
3 Methes Energies International Ltd (MEIL) 0.26 13.04% 2021-09-09 09:42:45
4 ProQR Therapeutics N.V. (PRQR) 7.66 12.48% 2021-09-09 15:51:11
5 Peloton (PTON) 107.08 9.83% 2021-09-09 15:12:33
6 Genocea Biosciences (GNCA) 2.04 9.68% 2021-09-09 02:46:05
7 MacroGenics (MGNX) 23.05 9.14% 2021-09-09 09:51:09
8 Liberty Media (LSXMB) 52.10 8.49% 2021-09-09 15:36:03
9 Euroseas Ltd. (ESEA) 24.95 8.48% 2021-09-08 23:41:05
10 Moderna (MRNA) 455.92 7.81% 2021-09-09 15:12:14

The three most active and biggest losers today are Helios and Matheson Analytics, InterCloud Systems, and Gulf Coast Ultra Deep Royalty Trust.

Rank Financial Asset Price Change Updated (EST)
1 Helios and Matheson Analytics (HMNY) 0.00 -57.14% 2021-09-09 04:05:15
2 InterCloud Systems (ICLD) 0.00 -40% 2021-09-09 04:55:12
3 Gulf Coast Ultra Deep Royalty Trust (GULTU) 0.02 -12.23% 2021-09-09 03:12:05
4 Mannatech (MTEX) 31.05 -9.23% 2021-09-09 10:52:10
5 Zai Lab (ZLAB) 136.99 -8.42% 2021-09-09 15:36:17
6 Emmis Communications Corporation (EMMS) 2.25 -8.16% 2021-09-08 23:11:05
7 Netlist (NLST) 5.56 -7.64% 2021-09-09 11:44:13
8 Kopin Corporation (KOPN) 5.57 -7.17% 2021-09-09 07:17:30
9 Box (BOX) 23.60 -6.9% 2021-09-09 15:44:15
10 Biogen (BIIB) 300.15 -6.66% 2021-09-09 15:07:32

Most Active Winners today

1. Gevo (GEVO) – 37.13%

NASDAQ Composite ended the session with Gevo jumping 37.13% to $7.94 on Thursday while NASDAQ Composite dropped 0.25% to $15,248.25.

Volume

Today’s last reported volume for Gevo is 179724000 which is 2330.02% above its average volume of 7395980.

Gevo’s last close was $6.16, 60.44% below its 52-week high of $15.57.

Gevo’s Sales

Gevo’s sales growth is a negative 57.3% for the current quarter and 40.6% for the next. The company’s growth estimates for the present quarter and the next is 87.5% and 12.5%, respectively.

Gevo’s Revenue

Year-on-year quarterly revenue growth declined by 92.3%, now sitting on 5.54M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Gevo’s stock is considered to be oversold (<=20).

Gevo’s Stock Yearly Top and Bottom Value

Gevo’s stock is valued at $7.94 at 17:32 EST, way below its 52-week high of $15.57 and way above its 52-week low of $0.77.

Gevo’s Moving Average

Gevo’s worth is way higher than its 50-day moving average of $5.85 and above its 200-day moving average of $7.23.

More news about Gevo.

2. ICU Medical (ICUI) – 26.23%

NASDAQ Composite ended the session with ICU Medical rising 26.23% to $260.00 on Thursday while NASDAQ Composite slid 0.25% to $15,248.25.

Volume

Today’s last reported volume for ICU Medical is 2958330 which is 2473.89% above its average volume of 114936.

ICU Medical’s last close was $202.78, 28.09% below its 52-week high of $282.00.

The company’s growth estimates for the ongoing quarter and the next is a negative 0.6% and a negative 5.3%, respectively.

ICU Medical’s Revenue

Year-on-year quarterly revenue growth declined by 3.2%, now sitting on 1.26B for the twelve trailing months.

ICU Medical’s Stock Yearly Top and Bottom Value

ICU Medical’s stock is valued at $260.00 at 17:32 EST, under its 52-week high of $282.00 and way above its 52-week low of $176.19.

ICU Medical’s Moving Average

ICU Medical’s worth is way above its 50-day moving average of $196.10 and way higher than its 200-day moving average of $203.26.

Previous days news about ICU Medical

  • Smiths agrees to sell smiths medical to ICU medical on superior deal terms. According to Business Insider on Wednesday, 8 September, "In addition to the initial net cash proceeds, Smiths will also receive 2.5 million new ICU Medical shares, worth $0.5 billion at ICU Medical’s closing share price on September 7 of $205.98. ", "The ICU offer carries future material upside through both participation in ICU Medical equity and a $0.1 billion ‘earnout’."
  • ICU medical recalls aminosyn ii, 15% amino acid injection. According to Business Insider on Wednesday, 8 September, "However, ICU Medical has not received reports of adverse events or illness related to this recall to date.", "The product was distributed nationwide by ICU Medical direct to customers and through medical distributors."

More news about ICU Medical.

3. Methes Energies International Ltd (MEIL) – 13.04%

NASDAQ Composite ended the session with Methes Energies International Ltd jumping 13.04% to $0.26 on Thursday while NASDAQ Composite slid 0.25% to $15,248.25.

Volume

Today’s last reported volume for Methes Energies International Ltd is 152923 which is 240.1% above its average volume of 44964.

Methes Energies International Ltd’s last close was $0.26, 73.47% under its 52-week high of $0.98.

Methes Energies International Ltd’s Revenue

Year-on-year quarterly revenue growth declined by 75.8%, now sitting on 3.72M for the twelve trailing months.

Methes Energies International Ltd’s Stock Yearly Top and Bottom Value

Methes Energies International Ltd’s stock is valued at $0.26 at 17:32 EST, way below its 52-week high of $0.98 and way higher than its 52-week low of $0.01.

Methes Energies International Ltd’s Moving Average

Methes Energies International Ltd’s worth is above its 50-day moving average of $0.24 and way higher than its 200-day moving average of $0.22.

More news about Methes Energies International Ltd.

4. ProQR Therapeutics N.V. (PRQR) – 12.48%

NASDAQ Composite ended the session with ProQR Therapeutics N.V. jumping 12.48% to $7.66 on Thursday while NASDAQ Composite fell 0.25% to $15,248.25.

Volume

Today’s last reported volume for ProQR Therapeutics N.V. is 14049000 which is 3002.85% above its average volume of 452779.

ProQR Therapeutics N.V.’s last close was $6.91, 26.96% under its 52-week high of $9.46.

ProQR Therapeutics N.V.’s Sales

ProQR Therapeutics N.V.’s sales growth is a negative 48.9% for the present quarter and a decline by 21.4% for the next. The company’s growth estimates for the current quarter is a negative 144.4% and positive 32.3% for the next.

ProQR Therapeutics N.V.’s Stock Yearly Top and Bottom Value

ProQR Therapeutics N.V.’s stock is valued at $7.66 at 17:32 EST, way below its 52-week high of $9.46 and way higher than its 52-week low of $3.40.

ProQR Therapeutics N.V.’s Moving Average

ProQR Therapeutics N.V.’s worth is way higher than its 50-day moving average of $6.07 and way higher than its 200-day moving average of $6.12.

More news about ProQR Therapeutics N.V..

5. Peloton (PTON) – 9.83%

NASDAQ Composite ended the session with Peloton rising 9.83% to $107.08 on Thursday while NASDAQ Composite fell 0.25% to $15,248.25.

Volume

Today’s last reported volume for Peloton is 16693900 which is 141.97% above its average volume of 6899030.

Peloton’s last close was $98.56, 42.39% below its 52-week high of $171.09.

News about Peloton today

  • Notable Peloton interactive insider trades $2.42 million in company stock. According to today’s article on Benzinga, "Mariana Garavaglia, Chief Operating Officer at Peloton Interactive (NASDAQ:PTON), made a large buy and sell of company shares on September 3, according to a new SEC filing.", "What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission reports that on September 3, Mariana Garavaglia bought 9,375 Peloton Interactive shares at a price of $26.69 per share, for a total of $250,219. "
  • Why Peloton shares are rising. According to today’s article on Benzinga, "Peloton says theinaugural collection for fall 2021 includes style-forward, expertly-crafted pieces that have been wear-tested by real Peloton Members, non-members and Peloton’s own instructors doing Peloton workouts across the platform’s various fitness modalities to ensure every style is high-performing and body-inclusive."

Peloton’s Sales

Peloton’s sales growth is 54.3% for the current quarter and 9.9% for the next. The company’s growth estimates for the current quarter and the next is a negative 266.7% and a negative 565%, respectively.

Peloton’s Revenue

Year-on-year quarterly revenue growth grew by 54.3%, now sitting on 4.02B for the twelve trailing months.

Peloton’s Stock Yearly Top and Bottom Value

Peloton’s stock is valued at $107.08 at 17:32 EST, way below its 52-week high of $171.09 and way higher than its 52-week low of $78.83.

Peloton’s Moving Average

Peloton’s worth is under its 50-day moving average of $113.12 and below its 200-day moving average of $110.28.

More news about Peloton.

6. Genocea Biosciences (GNCA) – 9.68%

NASDAQ Composite ended the session with Genocea Biosciences jumping 9.68% to $2.04 on Thursday while NASDAQ Composite fell 0.25% to $15,248.25.

Volume

Today’s last reported volume for Genocea Biosciences is 629157 which is 340.61% above its average volume of 142790.

Genocea Biosciences’s last close was $2.04, 49.57% below its 52-week high of $4.05.

The company’s growth estimates for the present quarter is a negative 150% and positive 17.4% for the next.

Genocea Biosciences’s Stock Yearly Top and Bottom Value

Genocea Biosciences’s stock is valued at $2.04 at 17:32 EST, way under its 52-week high of $4.05 and way higher than its 52-week low of $1.65.

Genocea Biosciences’s Moving Average

Genocea Biosciences’s worth is above its 50-day moving average of $1.90 and way below its 200-day moving average of $2.35.

More news about Genocea Biosciences.

7. MacroGenics (MGNX) – 9.14%

NASDAQ Composite ended the session with MacroGenics rising 9.14% to $23.05 on Thursday while NASDAQ Composite slid 0.25% to $15,248.25.

Volume

Today’s last reported volume for MacroGenics is 446792 which is 29.57% below its average volume of 634384.

MacroGenics’s last close was $22.50, 38.32% under its 52-week high of $36.48.

MacroGenics’s Sales

MacroGenics’s sales growth is 48.2% for the current quarter and 135.7% for the next. The company’s growth estimates for the present quarter and the next is 51.1% and 7.6%, respectively.

MacroGenics’s Revenue

Year-on-year quarterly revenue growth grew by 23.4%, now sitting on 108.08M for the twelve trailing months.

MacroGenics’s Stock Yearly Top and Bottom Value

MacroGenics’s stock is valued at $23.05 at 17:32 EST, way under its 52-week high of $36.48 and way above its 52-week low of $18.16.

MacroGenics’s Moving Average

MacroGenics’s worth is under its 50-day moving average of $23.96 and way below its 200-day moving average of $27.36.

More news about MacroGenics.

8. Liberty Media (LSXMB) – 8.49%

NASDAQ Composite ended the session with Liberty Media rising 8.49% to $52.10 on Thursday while NASDAQ Composite slid 0.25% to $15,248.25.

Volume

Today’s last reported volume for Liberty Media is 111 which is 158.13% above its average volume of 43.

Liberty Media’s last close was $52.10, 0% under its 52-week high of $52.10.

Liberty Media’s Revenue

Year-on-year quarterly revenue growth grew by 5.4%, now sitting on 8.15B for the twelve trailing months.

Liberty Media’s Stock Yearly Top and Bottom Value

Liberty Media’s stock is valued at $52.10 at 17:32 EST, way below its 52-week low of $33.91.

Liberty Media’s Moving Average

Liberty Media’s value is higher than its 50-day moving average of $49.74 and higher than its 200-day moving average of $47.42.

More news about Liberty Media.

9. Euroseas Ltd. (ESEA) – 8.48%

NASDAQ Composite ended the session with Euroseas Ltd. jumping 8.48% to $24.95 on Thursday, following the last session’s upward trend. NASDAQ Composite fell 0.25% to $15,248.25, following the last session’s downward trend on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Euroseas Ltd. is 125024 which is 55.03% above its average volume of 80641.

Euroseas Ltd.’s last close was $24.95, 6.13% below its 52-week high of $26.58.

The company’s growth estimates for the current quarter and the next is 14100% and 2571.4%, respectively.

Euroseas Ltd.’s Revenue

Year-on-year quarterly revenue growth grew by 35.4%, now sitting on 56.96M for the twelve trailing months.

Euroseas Ltd.’s Stock Yearly Top and Bottom Value

Euroseas Ltd.’s stock is valued at $24.95 at 17:32 EST, under its 52-week high of $26.58 and way above its 52-week low of $2.10.

Euroseas Ltd.’s Moving Average

Euroseas Ltd.’s worth is way higher than its 50-day moving average of $21.10 and way higher than its 200-day moving average of $16.86.

More news about Euroseas Ltd..

10. Moderna (MRNA) – 7.81%

NASDAQ Composite ended the session with Moderna jumping 7.81% to $455.92 on Thursday while NASDAQ Composite fell 0.25% to $15,248.25.

Volume

Today’s last reported volume for Moderna is 22038300 which is 27.81% above its average volume of 17242700.

Moderna’s last close was $416.70, 16.24% below its 52-week high of $497.49.

News about Moderna today

  • Moderna says it has about $15 billion in cash, working on combined covid/seasonal flu booster. According to today’s article on MarketWatch, "The company made the disclosure as it offered an update on its line of product candidates based on mRNA technology, that includes a vaccine against COVID-19, the first Moderna product to win authorization from the U.S. Food and Drug Administration. "

Moderna’s Sales

Moderna’s sales growth is 6241.2% for the current quarter and 8216.6% for the next. The company’s growth estimates for the ongoing quarter and the next is 2019.4% and 1696.6%, respectively.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 6398.5%, now sitting on 7.02B for the twelve trailing months.

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $455.92 at 17:32 EST, below its 52-week high of $497.49 and way higher than its 52-week low of $54.51.

Moderna’s Moving Average

Moderna’s value is way above its 50-day moving average of $383.20 and way above its 200-day moving average of $228.60.

Previous days news about Moderna

  • Pfizer Covid-19 booster shots likely to be ready sept. 20, but Moderna May be delayed : reports. According to Business Insider on Monday, 6 September, "The Biden administration has announced plans to offer third doses to people who received the Pfizer and Moderna shots, pending approval from public health officials. ", "Meanwhile, Moderna last week said it submitted documents asking approval from the U.S. Food and Drug Administration to allow the use of a third booster dose of its COVID-19 vaccine."
  • Bitcoin, Moderna, Tesla, Boeing, and 'the dogecoin wife:' 5 headlines you May have missed from labor day weekend. According to Benzinga on Tuesday, 7 September, "Moderna Boosters Could Face Delay: Moderna Inc.’s (NASDAQ: MRNA) COVID-19 booster shot may not be rolled out in the week of Sept. 20 as the company is yet to submit the required data to the U.S. Food and Drug Administration, according to U.S. President Joe Biden’s Chief Medical Adviser Anthony Fauci. "

More news about Moderna.

Most Active Losers Today

1. Helios and Matheson Analytics (HMNY) – -57.14%

NASDAQ Composite ended the session with Helios and Matheson Analytics sliding 57.14% to $0.00 on Thursday, after four successive sessions in a row of losses. NASDAQ Composite dropped 0.25% to $15,248.25, following the last session’s downward trend on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for Helios and Matheson Analytics is 24241600 which is 131.97% above its average volume of 10450100.

Helios and Matheson Analytics’s last close was $0.00, 96% under its 52-week high of $0.02.

Helios and Matheson Analytics’s Sales

Helios and Matheson Analytics’s sales growth is 923.6% for the current quarter and 329.5% for the next.

Helios and Matheson Analytics’s Revenue

Year-on-year quarterly revenue growth grew by 6268.3%, now sitting on 205.08M for the twelve trailing months.

Helios and Matheson Analytics’s Stock Yearly Top and Bottom Value

Helios and Matheson Analytics’s stock is valued at $0.00 at 17:32 EST, below its 52-week low of $0.00.

Helios and Matheson Analytics’s Moving Average

Helios and Matheson Analytics’s worth is below its 50-day moving average of $0.00 and below its 200-day moving average of $0.00.

More news about Helios and Matheson Analytics.

2. InterCloud Systems (ICLD) – -40%

NASDAQ Composite ended the session with InterCloud Systems sliding 40% to $0.00 on Thursday while NASDAQ Composite dropped 0.25% to $15,248.25.

Volume

Today’s last reported volume for InterCloud Systems is 770405 which is 79.34% below its average volume of 3729310.

InterCloud Systems’s last close was $0.00, 96.2% under its 52-week high of $0.01.

InterCloud Systems’s Revenue

Year-on-year quarterly revenue growth declined by 54.7%, now sitting on 32.85M for the twelve trailing months.

InterCloud Systems’s Stock Yearly Top and Bottom Value

InterCloud Systems’s stock is valued at $0.00 at 17:32 EST, under its 52-week low of $0.00.

InterCloud Systems’s Moving Average

InterCloud Systems’s worth is under its 50-day moving average of $0.00 and under its 200-day moving average of $0.00.

More news about InterCloud Systems.

3. Gulf Coast Ultra Deep Royalty Trust (GULTU) – -12.23%

NASDAQ Composite ended the session with Gulf Coast Ultra Deep Royalty Trust falling 12.23% to $0.02 on Thursday while NASDAQ Composite dropped 0.25% to $15,248.25.

Volume

Today’s last reported volume for Gulf Coast Ultra Deep Royalty Trust is 57848 which is 3.94% below its average volume of 60226.

Gulf Coast Ultra Deep Royalty Trust’s last close was $0.02, 60% below its 52-week high of $0.05.

Gulf Coast Ultra Deep Royalty Trust’s Revenue

Year-on-year quarterly revenue growth grew by 19.9%, now sitting on 808.01k for the twelve trailing months.

Gulf Coast Ultra Deep Royalty Trust’s Stock Yearly Top and Bottom Value

Gulf Coast Ultra Deep Royalty Trust’s stock is valued at $0.02 at 17:32 EST, way under its 52-week high of $0.05 and way higher than its 52-week low of $0.01.

Gulf Coast Ultra Deep Royalty Trust’s Moving Average

Gulf Coast Ultra Deep Royalty Trust’s worth is way below its 50-day moving average of $0.03 and way below its 200-day moving average of $0.03.

More news about Gulf Coast Ultra Deep Royalty Trust.

4. Mannatech (MTEX) – -9.23%

NASDAQ Composite ended the session with Mannatech falling 9.23% to $31.05 on Thursday, after two consecutive sessions in a row of gains. NASDAQ Composite dropped 0.25% to $15,248.25, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for Mannatech is 12594 which is 3.72% below its average volume of 13081.

Mannatech’s last close was $33.50, 31.74% below its 52-week high of $49.08.

Mannatech’s Revenue

Year-on-year quarterly revenue growth declined by 0.5%, now sitting on 151.41M for the twelve trailing months.

Mannatech’s Stock Yearly Top and Bottom Value

Mannatech’s stock is valued at $31.05 at 17:32 EST, way under its 52-week high of $49.08 and way higher than its 52-week low of $13.65.

Mannatech’s Moving Average

Mannatech’s worth is higher than its 50-day moving average of $30.29 and way higher than its 200-day moving average of $24.11.

More news about Mannatech.

5. Zai Lab (ZLAB) – -8.42%

NASDAQ Composite ended the session with Zai Lab sliding 8.42% to $136.99 on Thursday, after two successive sessions in a row of losses. NASDAQ Composite dropped 0.25% to $15,248.25, following the last session’s downward trend on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Zai Lab is 335456 which is 34.96% below its average volume of 515776.

Zai Lab’s last close was $145.57, 24.79% below its 52-week high of $193.54.

Zai Lab’s Revenue

Year-on-year quarterly revenue growth grew by 235.9%, now sitting on 86.78M for the twelve trailing months.

Zai Lab’s Stock Yearly Top and Bottom Value

Zai Lab’s stock is valued at $136.99 at 17:32 EST, way under its 52-week high of $193.54 and way above its 52-week low of $72.42.

Zai Lab’s Moving Average

Zai Lab’s worth is under its 50-day moving average of $144.24 and way below its 200-day moving average of $153.18.

More news about Zai Lab.

6. Emmis Communications Corporation (EMMS) – -8.16%

NASDAQ Composite ended the session with Emmis Communications Corporation dropping 8.16% to $2.25 on Thursday while NASDAQ Composite dropped 0.25% to $15,248.25.

Volume

Today’s last reported volume for Emmis Communications Corporation is 661 which is 92.3% below its average volume of 8588.

Emmis Communications Corporation’s last close was $2.25, 21.88% below its 52-week high of $2.88.

Emmis Communications Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 15.9%, now sitting on 39.71M for the twelve trailing months.

Emmis Communications Corporation’s Stock Yearly Top and Bottom Value

Emmis Communications Corporation’s stock is valued at $2.25 at 17:32 EST, way under its 52-week high of $2.88 and way higher than its 52-week low of $1.49.

Emmis Communications Corporation’s Moving Average

Emmis Communications Corporation’s worth is under its 50-day moving average of $2.25 and way under its 200-day moving average of $2.54.

More news about Emmis Communications Corporation.

7. Netlist (NLST) – -7.64%

NASDAQ Composite ended the session with Netlist falling 7.64% to $5.56 on Thursday, following the last session’s downward trend. NASDAQ Composite dropped 0.25% to $15,248.25, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Netlist is 1428330 which is 33.69% below its average volume of 2154290.

Netlist’s last close was $6.27, 38.53% below its 52-week high of $10.20.

Netlist’s Revenue

Year-on-year quarterly revenue growth grew by 490.2%, now sitting on 100.96M for the twelve trailing months.

Netlist’s Stock Yearly Top and Bottom Value

Netlist’s stock is valued at $5.56 at 17:32 EST, way under its 52-week high of $10.20 and way above its 52-week low of $0.44.

Netlist’s Moving Average

Netlist’s value is way under its 50-day moving average of $7.18 and way above its 200-day moving average of $3.75.

More news about Netlist.

8. Kopin Corporation (KOPN) – -7.17%

NASDAQ Composite ended the session with Kopin Corporation dropping 7.17% to $5.57 on Thursday, after two successive sessions in a row of gains. NASDAQ Composite dropped 0.25% to $15,248.25, following the last session’s downward trend on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Kopin Corporation is 2012020 which is 1.42% below its average volume of 2041020.

Kopin Corporation’s last close was $5.85, 57.05% below its 52-week high of $13.62.

Kopin Corporation’s Sales

Kopin Corporation’s sales growth is 26.6% for the ongoing quarter and 8.3% for the next.

Kopin Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 48.2%, now sitting on 43.93M for the twelve trailing months.

Kopin Corporation’s Stock Yearly Top and Bottom Value

Kopin Corporation’s stock is valued at $5.57 at 17:32 EST, way under its 52-week high of $13.62 and way higher than its 52-week low of $1.17.

Kopin Corporation’s Moving Average

Kopin Corporation’s worth is below its 50-day moving average of $5.92 and way below its 200-day moving average of $7.82.

More news about Kopin Corporation.

9. Box (BOX) – -6.9%

NYSE Composite ended the session with Box falling 6.9% to $23.60 on Thursday, following the last session’s downward trend. NYSE Composite slid 0.42% to $16,731.05, after two sequential sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Box is 4938000 which is 111.41% above its average volume of 2335720.

Box’s last close was $24.63, 10.14% below its 52-week high of $27.41.

News about Box today

  • Starboard push for box board nominees is said to fall short. According to today’s article on Bloomberg Quint, "Total shareholder returns have been more than 70% since Starboard first disclosed its stake in Box in September 2019. ", "The activist managed to win the support of some Box investors, including P. Schoenfeld Asset Management, which said the KKR financing was just the the latest example of the board exercising poor corporate governance."

The company’s growth estimates for the current quarter and the next is 5.6% and 5%, respectively.

Box’s Revenue

Year-on-year quarterly revenue growth grew by 13.6%, now sitting on 676.39M for the twelve trailing months.

Box’s Stock Yearly Top and Bottom Value

Box’s stock is valued at $23.60 at 17:32 EST, way below its 52-week high of $27.41 and way above its 52-week low of $15.07.

Box’s Moving Average

Box’s worth is below its 50-day moving average of $24.65 and higher than its 200-day moving average of $22.65.

More news about Box.

10. Biogen (BIIB) – -6.66%

NASDAQ Composite ended the session with Biogen sliding 6.66% to $300.15 on Thursday while NASDAQ Composite dropped 0.25% to $15,248.25.

Volume

Today’s last reported volume for Biogen is 3511390 which is 140.45% above its average volume of 1460300.

Biogen’s last close was $333.60, 28.8% under its 52-week high of $468.55.

News about Biogen today

  • Biogen loses $7 billion in value on slow alzheimer’s drug rollout. According to today’s article on Bloomberg Quint, "He sees little gains for Biogen ahead of a key Medicare decision on coverage, a proposed plan isn’t expected until 2022."

The company’s growth estimates for the current quarter and the next is a negative 53.1% and a negative 23.8%, respectively.

Biogen’s Revenue

Year-on-year quarterly revenue growth declined by 24.6%, now sitting on 11.7B for the twelve trailing months.

Biogen’s Stock Yearly Top and Bottom Value

Biogen’s stock is valued at $300.15 at 17:32 EST, way under its 52-week high of $468.55 and way higher than its 52-week low of $223.25.

Biogen’s Moving Average

Biogen’s worth is way below its 50-day moving average of $336.96 and below its 200-day moving average of $308.85.

More news about Biogen.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here